Zoetis launches first-in-class equine leptospirosis vaccine; Gour teams with IDEXX on dog dermatitis drug; Jaguar inks development deal with Patheon;

> Zoetis ($ZTS) introduced Lepto EQ Innovator, the first USDA-approved equine-specific vaccine to prevent leptospirosis in horses. Article

> Gour Medical signed an agreement with IDEXX ($IDXX) to develop a recombinant monoclonal antibody for the treatment and prevention of atopic dermatitis in dogs. Release

> Jaguar Animal Health ($JAGX) signed a contract with Patheon for the development and manufacturing of crofelemer, an active ingredient in Canalevia, its lead prescription drug candidate for the treatment of diarrhea in dogs. Release

> The Center for Food Safety released a new report urging the FDA to improve its oversight of animal drugs and suggesting that some products on the market pose a threat to animals, people and the environment. Release

> Aratana Therapeutics ($PETX) announced it has refinanced a $15 million loan with a a $40 million senior secured credit facility consisting of a $35 million term loan and a $5 million revolving loan. Release

> Animalcare Group recorded sales growth of 5% year-over-year to GBP 13.5 million ($20.7 million) for the fiscal year ended June 30. Article

> Scientists at UC San Francisco have put out a call for hospitals to help stop the spread of antibiotics-resistant infections by not buying meat from producers that use the drugs to promote the growth of food animals. Release

> Researchers at Kansas State University have determined that reducing inflammation during the birthing process helps dairy cows recover more quickly and improves their production over time. Release